| Year |
Citation |
Score |
| 2018 |
Han S, Gonzalo DH, Feely M, Rinaldi C, Belsare S, Zhai H, Kalra K, Gerber MH, Forsmark CE, Hughes SJ. Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells. Oncotarget. 9: 5764-5777. PMID 29464032 DOI: 10.18632/Oncotarget.23532 |
0.423 |
|
| 2018 |
Meo AD, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM. A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization. Oncotarget. 9: 2092-2104. PMID 29416756 DOI: 10.18632/Oncotarget.23162 |
0.406 |
|
| 2017 |
Yang J, Ma D, Fesler A, Zhai H, Leamniramit A, Li W, Wu S, Ju J. Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Oncotarget. 8: 52403-52412. PMID 28881738 DOI: 10.18632/Oncotarget.14175 |
0.416 |
|
| 2016 |
Yang J, Ma D, Fesler A, Zhai H, Leamniramit A, Li W, Wu S, Ju J. Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Oncotarget. PMID 28039449 DOI: 10.18632/oncotarget.14175 |
0.325 |
|
| 2016 |
Ma D, Xue Y, Fesler A, Zhai H, Yang J, Ieamniramit A, Li W, Ju J. Abstract 1968: Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer Cancer Research. 76: 1968-1968. DOI: 10.1158/1538-7445.Am2016-1968 |
0.365 |
|
| 2015 |
Zhai H, Fesler A, Ba Y, Wu S, Ju J. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget. 6: 19735-46. PMID 25980495 DOI: 10.18632/Oncotarget.3771 |
0.446 |
|
| 2015 |
Zhai H, Fesler A, Ju J. Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy Cancer Research. 75: 3117-3117. DOI: 10.1158/1538-7445.Am2015-3117 |
0.445 |
|
| 2015 |
Fesler A, Zhai H, Ju J. Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer Cancer Research. 75: 3079-3079. DOI: 10.1158/1538-7445.Am2015-3079 |
0.443 |
|
| 2014 |
Fesler A, Zhai H, Ju J. miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. Oncotargets and Therapy. 7: 1481-5. PMID 25187728 DOI: 10.2147/Ott.S65548 |
0.377 |
|
| 2014 |
Fesler A, Jiang J, Zhai H, Ju J. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients. Molecular Diagnosis & Therapy. 18: 303-8. PMID 24566942 DOI: 10.1007/S40291-014-0089-0 |
0.33 |
|
| 2014 |
Patel P, Ma Y, Zhai H, Ju J, Chen E. Abstract PR13: Using a hypoxia-induced CSC tumor initiation model to improve predictive potential for patients with metastatic breast cancer Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-Pr13 |
0.344 |
|
| 2013 |
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Prognostic significance of miR-194 in endometrial cancer. Biomarker Research. 1. PMID 24040515 DOI: 10.1186/2050-7771-1-12 |
0.415 |
|
| 2013 |
Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clinical Colorectal Cancer. 12: 261-6. PMID 24012455 DOI: 10.1016/J.Clcc.2013.06.003 |
0.301 |
|
| 2013 |
Karaayvaz M, Zhai H, Ju J. miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death & Disease. 4: e659. PMID 23744359 DOI: 10.1038/Cddis.2013.193 |
0.436 |
|
| 2013 |
Zhai H, Fesler A, Ju J. MicroRNA: a third dimension in autophagy. Cell Cycle (Georgetown, Tex.). 12: 246-50. PMID 23255136 DOI: 10.4161/Cc.23273 |
0.336 |
|
| 2013 |
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Abstract 5293: Prognostic significance of miR-194 in endometrial cancer. Cancer Research. 73: 5293-5293. DOI: 10.1158/1538-7445.Am2013-5293 |
0.422 |
|
| 2013 |
Karaayvaz M, Zhai H, Ju J. Abstract 4185: miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity. Cancer Research. 73: 4185-4185. DOI: 10.1158/1538-7445.Am2013-4185 |
0.451 |
|
| 2013 |
Zhai H, Fesler A, Schee K, Fodstad Ø, Flatmark K, Ju J. Abstract 1840: Clinical significance of lincRNA-p21 in colorectal cancer. Cancer Research. 73: 1840-1840. DOI: 10.1158/1538-7445.Am2013-1840 |
0.319 |
|
| 2012 |
Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, Tsirka SE, Santambrogio L, Hajjar KA. The annexin A2/S100A10 system in health and disease: Emerging paradigms Journal of Biomedicine and Biotechnology. 2012. PMID 23193360 DOI: 10.1155/2012/406273 |
0.516 |
|
| 2012 |
Zhai H, Song B, Xu X, Zhu W, Ju J. Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene. 32: 1570-9. PMID 22580605 DOI: 10.1038/Onc.2012.167 |
0.431 |
|
| 2012 |
Zhai H, Song B, Xu X, Zhu W, Ju J. Abstract 2285: Inhibition of autophagy and tumor growth in colon cancer by miR-502 Cancer Research. 72: 2285-2285. DOI: 10.1158/1538-7445.Am2012-2285 |
0.44 |
|
| 2011 |
Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Frontiers in Genetics. 2. PMID 22114584 DOI: 10.3389/Fgene.2011.00078 |
0.347 |
|
| 2011 |
Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 14346-60. PMID 21976520 DOI: 10.1523/Jneurosci.3299-11.2011 |
0.55 |
|
| 2011 |
Zhai H, Heppner FL, Tsirka SE. Microglia/macrophages promote glioma progression Glia. 59: 472-485. PMID 21264953 DOI: 10.1002/Glia.21117 |
0.503 |
|
| Show low-probability matches. |